Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Zydus

Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test

Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health. This innovative blood test can identify signals for multiple cancer types in individuals aged 45 and above. The collaboration aims to enhance early cancer detection and…

The Economic Times

Cholesterol and Heart Medications Were Recalled Early This Year — Here Is What Statin Users Should Check

AvKARE recalled rosuvastatin and Zydus recalled Icosapent Ethyl tablets early 2026 for manufacturing defects. Here are the affected lot numbers and what heart medication patients should do.

Medical Daily

Zydus, Sunshine to set up $20 million pharma JV in Sri Lanka

Indian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing facility. This $20 million joint venture, Zydus Sunshine Lifesciences, will be located in the Horana Export Processing Zone. The project aims to boost local drug production, decrease reliance on imports, and improve…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 million

Zydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized through a subsidiary, makes Assertio a wholly-owned entity, bolstering Zydus's specialty and oncology supportive-care therapies pipeline. This strategic move aims to enhance the company's innovative drug offerings.

The Economic Times

Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?

Zydus Lifesciences shares climbed to a new 52-week high. The company reported a 9% rise in net profit and over 16% revenue growth for the January-March quarter. A Rs 1,100 crore share buyback was announced. Analysts from Nomura, Nuvama, Motilal Oswal, and JM Financial shared their views on the company's…

The Economic Times

Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisition

Zydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. The stock also gained momentum as Zydus announced a $166 million acquisition of US-based Assertio. Investor sentiment improved on expectations of capital return and strategic business…

The Economic Times

Stocks in news: HAL, TMPV, Bharti Airtel, Anant Raj, Zydus Life, Tata Motors

Indian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL, Tata Motors, and Bharti Airtel are in focus due to quarterly results and news developments. Zydus Lifesciences is nearing a US acquisition, while Maruti Suzuki commits to green logistics.

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

Zydus gets USFDA approval for generic drug

The drug is used to treat high blood pressure in the lungs

The Hindu

Zydus starts supply of its needle-free 3-dose vaccine to govt

MUMBAI: Pharma major Zydus Cadila said on Wednesday it has started supplying its Covid-19 vaccine ZyCoV-D to the Centre, nearly six months after it had been authorised for emergency use in the 12 and above age group.

The Times of India

Zydus commences supply of COVID-19 vaccine ZyCoV-D to Central govt

Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad.

Organisations

Assertio Holdings Inc

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.